Top Markets
#1 Akedo Akedo +63.85%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.67%
#4 Cross Cross +44.24%
#5 Black Phoenix Black Phoenix +34.14%
#6 Velvet Velvet +29.70%
#7 OVERTAKE OVERTAKE +26.36%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.57%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.55%
#10 Palladium Network Palladium Network +12.47%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Aravive, Inc. Aravive, Inc.

Aravive, Inc.

ARAV
Rang in Aktien #38757
Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston,... Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston, Texas, dedicated to discovering and developing innovative treatments for life-threatening illnesses such as cancer and fibrosis. The company's primary therapeutic candidate, batiraxcept, is an ultrahigh-affinity decoy protein engineered to disrupt the GAS6-AXL signaling pathway. This drug is currently progressing through a Phase III clinical trial for platinum-resistant recurrent ovarian cancer, and is also being evaluated in Phase Ib/II studies for clear cell renal cell carcinoma and pancreatic adenocarcinoma. Aravive also has AVB-S6 in its pipeline, a soluble Fc-fusion protein aimed at blocking the activation of the same GAS6-AXL pathway. Beyond internal development, Aravive has forged strategic partnerships. This includes a collaboration with WuXi Biologics (Hong Kong) Limited to develop novel, high-affinity bispecific antibodies targeting cancer and fibrosis. Furthermore, a license agreement with 3D Medicines Inc. grants rights to develop and commercialize products featuring batiraxcept as the sole active ingredient for human oncological diseases across mainland China, Taiwan, Hong Kong, and Macau. Originally incorporated in 2008 as Versartis, Inc., the company adopted the name Aravive, Inc. in October 2018.
Aktienkurs
$0.0401
Zuletzt synchronisiert: 2024-02-07
Marktkapitalisierung
$818.60K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Aravive, Inc. (ARAV)

Kategorie

Healthcare
Preis ARAV mit Marktkapitalisierung von B
Aravive, Inc. Aravive, Inc.
ARAV
$0.0401
Marktkapitalisierung von Aravive, Inc.(ARAV)
Marktkapitalisierung: $818.60K
Mit Stand August 2026 hat Aravive, Inc. eine Marktkapitalisierung von $818.60K. Das macht Aravive, Inc. laut unseren Daten zum 38757th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Aravive, Inc. von 2014 bis 2026
ARAV im Vergleich zu den Top 5 der beliebtesten stocks
Preis für ARAV Vermögenswert B Marktkapitalisierung von B Ergebnisse
Aravive, Inc. Aravive, Inc.
$268,325 $818.60K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.478T +669,138,646.89%
Aravive, Inc. Aravive, Inc.
$219,861 $818.60K
Apple Inc. Apple Inc.
AAPL
$4.488T +548,280,853.07%
Aravive, Inc. Aravive, Inc.
$203,951 $818.60K
Alphabet Inc. Alphabet Inc.
GOOG
$4.163T +508,606,903.87%
Aravive, Inc. Aravive, Inc.
$181,467 $818.60K
Microsoft Corporation Microsoft Corporation
MSFT
$3.704T +452,534,965.78%
Aravive, Inc. Aravive, Inc.
$139,193 $818.60K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.841T +347,114,865.23%